Children with Dyslexia find it difficult to read at grade level. New research has some suggestions as to why that tend to happen. Atomoxetine was the subject of recent research, which was once used to treat ADHD. Students with Dyslexia may benefit from taking the drug regularly. It was compared against the effects of taking a placebo.
Researchers say Atomoxetine drug may help children with dyslexia.
As predicted, research showed that students taking the drug improved their reading. The study period lasted 16 weeks and compared results across a number of factors. But there is new research that supports the use of these drugs on the whole. Parents should take note and be ready to put their children on medication that could improve their performance in the classroom too.
Key takeaways
- Atomoxetine is a new dyslexia medication that is being researched.
- Atomoxetine began as a medication to assist with ADHD symptoms.
- Atomoxetine seemingly reduces both ADHD and dyslexia struggles.
See MTSS for schools
Is your child struggling in school?
Get your free personalized learning roadmap
You describe what you see at home. We turn it into a plan you start this week.
- Answer 5 short questionnaires about what you already notice, 30–45 minutes at your own kitchen table
- Your child sits no test and gets no score: nothing to schedule, nothing for them to dread
- You do the answering, the AI does the writing, and a person reviews it before it reaches you
- Access all 40+ courses instantly: reading, math, focus, processing and more, with new ones added regularly
Why we use AI, plainly: it writes from a knowledge base our team maintains and audits. We work through it line by line and pull anything the evidence stops supporting. The roadmap you get on Tuesday reflects what we corrected on Monday, and a human still reads it before you do.
Your school district must evaluate your child free of charge if you ask in writing, whatever your income and whatever the outcome (US, 34 CFR 300.111 and 300.301(b)). That route takes time and answers a different question than you do. This one starts today, from what you already know.
Your answers stay yours. We do not sell your personal information, and we do not hand identifiable assessment data to outside AI companies to train their models.
A screener is a starting point, not a diagnosis. If your child might need formal accommodations (an IEP or 504 plan), or you suspect a vision, hearing or medical cause, pursue a professional evaluation too. That is the only route to those supports.
